Search company, investor...
Hertility company logo


Founded Year



Seed VC | Alive

Total Raised


Last Raised

$5.91M | 1 yr ago

About Hertility

Hertility helps women better understand their reproductive health by offering a proactive hormone test that gives insight into egg count, ovulation, and the interplay between general health and reproductive biology.

Headquarters Location

International House Constance Street

London, England, E16 2DQ,

United Kingdom

Missing: Hertility's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Hertility's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Hertility

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Hertility in 2 CB Insights research briefs, most recently on Aug 31, 2022.

Expert Collections containing Hertility

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Hertility is included in 2 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,482 items

Startups focused on providing products and services catering to women's health and wellbeing.


Beauty & Personal Care

858 items

These startups aim to provide health treatments, diagnosis tools, and products that do not require a prescription or connection with a health professional to enhance personal wellbeing. This includes supplements, women's health maintenance, OTC medicines, and more.

Latest Hertility News

‘I was able to test and see where my ovarian reserve was going, I knew I didn’t have that time’

Aug 4, 2022

It’s actually fundamentally changed my life because I tested so proactively It helped Deirdre to make the life-changing decision to have a second child – far earlier than she had planned. “Everyone says, ‘I’ll have one, and we’ll kick the can down the road, we’ll deal with that another time.’ “But because I was able to test and see where my ovarian reserve was going, I knew I didn’t have that time. It’s actually fundamentally changed my life because I tested so proactively.” In Ireland, Hertility will be going head-to-head with one of the country's newest tech unicorns, LetsGetChecked, which is riding a pandemic boom in at-home health testing. Hertility’s service is tailored to women because of what Helen and Deirdre O’Neill say is a lack of public resources, the eye-watering cost of private treatment and a “psychological barrier” for young women, who are less inclined to think about their reproductive health. Read More The UK’s National Health Service (NHS) requires women to be “trying” for a baby for at least a year, or to have had “multiple miscarriages”, before they are offered a fertility test, Helen says. It costs thousands of pounds to attend a private clinic. In January, Sinn Féin TD Sorca Clarke revealed that around 36,000 women in Ireland were waiting for gynaecology appointments. Over 4,000 had been waiting more than 18 months, according to figures released to her on the back of a parliamentary question. “It’s barbaric,” Deirdre says. When Helen attempted to find out about her own reproductive health, she was met with “dismissal” and found the process very “confusing”, despite her 15 years of experience and research in the field. The Hertility founders hope their service will get more women, and men, talking about fertility, removing some of the stigma and squeamishness around it. A third of women surveyed by Hertility say men have “physically shuddered” when they discuss female health problems. And almost half have avoided talking about their health problems in front of men to avoid making them “uncomfortable”. Since last year, the sisters and their co-founder have been building up their team of 40-50 lab technicians and after-care specialists in the UK, and plan to replicate that in Ireland. They already have four doctors on board here and hope to partner with clinics, like they do in the UK, that can offer in-person follow-up care to women who need it. Funded by a grant from the UK government’s innovation agency, Innovate UK, and seed funding of £4.2m (raised last year and worth around €5m today), Hertility is now embarking on an open-ended Series A round. But it’s been a hard slog, they say. According to the Irish Venture Capital Association (IVCA), investors are increasingly piling into bigger deals, with amounts under €1m down by a third in the first quarter of 2022, and deals of between €1m and €5m down by half. The proportion of funding going to female-led startups has remained static in recent years, with women-led firms raising just 1.8pc of all investment in Europe in 2021. Add to that the scepticism about the service among some venture capitalists (VCs) the O’Neills have tapped. The female VCs are as bad as the male VCs “The female VCs are as bad as the male VCs,” says Deirdre. “The amount of female VCs we speak to who say, ‘We love this, we’ve used this, we’ve recommended this to our friends, but we’re not going to invest.’ “They go back to the male board and the male board guy goes, ‘I’m not sure that enough women need this.” “The question we get from male investors is, ‘So what would make a woman want to test?’ Helen says. “And we’re like, ‘We get monthly reminders when things are wrong.’” When the sisters set up their website during the pandemic – they had to hold off on in-person trials for obvious reasons – they registered interest from 7,000 women. “It’s infuriating,” Deirdre says. “Every VC out there says we want to invest in women. It’s all rhetoric.” “That’s a PC term for bullshit,” says Helen. The sisters are proud of their all-female research team, although they have more male than female doctors on their books. “When it came to hiring for tech, people were like, ‘Well, surely a developer doesn’t need to be female,” Helen says. “And we were like, ‘No, but it does help.’ Because the one guy we did get in put a drop-down menu for ‘How long does your period last?’ of 100 days. A female developer would know [better].” Just don’t call them femtech. It’s something that I would certainly move home for “We’re aware that is something that is not necessarily what investors want to hear,” says Helen. “What investors do want to hear is that, if they’re investing in the femtech space, that you are femtech. “We’ll happily accept the term femtech if that’s what the investors want. But to me, it’s a total dismissal and an under-representation of what we’ve achieved.” The O’Neills hope the Irish market, with its plethora of multinationals willing to shell out on employee benefits, will prove an easier sell than the UK. “You can’t imagine how hard it is to launch a healthcare business in a country where the NHS pays for everything,” says Helen. “Ireland, being home to all of the multinationals and headquarters to all of the major global companies, means that, from an employee standpoint, this would be a really welcome benefit.” It’s also a ticket home for the London-based twins, who have spent 15 years in the UK capital. “It’s something that I would certainly move home for,” says Deirdre. “I definitely want to head back home within the next few years.”

Hertility Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Hertility Rank

Hertility Frequently Asked Questions (FAQ)

  • When was Hertility founded?

    Hertility was founded in 2019.

  • Where is Hertility's headquarters?

    Hertility's headquarters is located at International House, London.

  • What is Hertility's latest funding round?

    Hertility's latest funding round is Seed VC.

  • How much did Hertility raise?

    Hertility raised a total of $5.91M.

  • Who are the investors of Hertility?

    Investors of Hertility include Phoenix Court Group, Matt Robinson, Evelyn Bourke and Venrex.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.